Browsing Tag
Antigen
26 posts
HEROS 2.0 trial results published
Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of…
April 24, 2024
New trials show promise for immune checkpoint blockers in early-stage lung cancer
In a recent phase I trial published in the journal Cell Reports Medicine, researchers from Belgium administered a…
April 18, 2024
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels
For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of…
April 17, 2024
Research unveils bispecific antibodies for B-cell lymphoma treatment
A new research paper was published in Oncotarget’s Volume 15 on April 12, 2024, entitled, “Novel therapeutic bispecific…
April 16, 2024
Genetically engineering skin bacteria to fight cancer
While studying a type of bacteria that lives on the healthy skin of every human being, researchers from…
April 15, 2024
New genetic variants could raise a woman’s risk of cervical cancer from HPV infections
Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each…
April 12, 2024
A balanced take on microbes and disease outcomes
In a recent review published in the journal PNAS, researchers examined the germ theory from a non-centric perspective…
April 11, 2024
Educational video boosts prostate cancer screening intentions in men
As part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Medicine’s Abramson Cancer Center…
April 10, 2024
Researchers find new clues to understanding the progression of primary membranous nephropathy
No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the…
April 10, 2024
Lancet Commission predicts sharp increase in global prostate cancer cases
Cases of prostate cancer are projected to double from 1.4 million per year in 2020 to 2.9 million…
April 5, 2024